18 May 2013
Keywords: gsk, decide, soon, exelixis, drug, option, notified
Article | 11 August 2008
Exelixis has notified partner GlaxoSmithKline that it has achieved proof-of-concept for XL184 under an October 2002 collaboration with the
UK drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 August 2008
17 May 2013
© 2013 thepharmaletter.com